Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 230

1.

Genetics of neurodegeneration with brain iron accumulation.

Gregory A, Hayflick SJ.

Curr Neurol Neurosci Rep. 2011 Jun;11(3):254-61. doi: 10.1007/s11910-011-0181-3. Review.

PMID:
21286947
2.
4.

Mitochondrial localization of human PANK2 and hypotheses of secondary iron accumulation in pantothenate kinase-associated neurodegeneration.

Johnson MA, Kuo YM, Westaway SK, Parker SM, Ching KH, Gitschier J, Hayflick SJ.

Ann N Y Acad Sci. 2004 Mar;1012:282-98.

PMID:
15105273
5.

Neurodegeneration with brain iron accumulation: clinical, radiographic and genetic heterogeneity and corresponding therapeutic options.

Clement F, Devos D, Moreau C, Coubes P, Destee A, Defebvre L.

Acta Neurol Belg. 2007 Mar;107(1):26-31.

PMID:
17569231
6.
7.

Excess iron harms the brain: the syndromes of neurodegeneration with brain iron accumulation (NBIA).

Schneider SA, Bhatia KP.

J Neural Transm (Vienna). 2013 Apr;120(4):695-703. doi: 10.1007/s00702-012-0922-8. Epub 2012 Dec 2. Review.

PMID:
23212724
8.

Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome.

Hayflick SJ, Westaway SK, Levinson B, Zhou B, Johnson MA, Ching KH, Gitschier J.

N Engl J Med. 2003 Jan 2;348(1):33-40.

9.

Clinicopathological variability in neurodegeneration with brain iron accumulation.

Vincze A, Kapás I, Molnar MJ, Kovács GG.

Ideggyogy Sz. 2010 Mar 30;63(3-4):129-35.

PMID:
20405671
10.

Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation.

Hartig MB, Hörtnagel K, Garavaglia B, Zorzi G, Kmiec T, Klopstock T, Rostasy K, Svetel M, Kostic VS, Schuelke M, Botz E, Weindl A, Novakovic I, Nardocci N, Prokisch H, Meitinger T.

Ann Neurol. 2006 Feb;59(2):248-56.

PMID:
16437574
12.
13.

A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome.

Zhou B, Westaway SK, Levinson B, Johnson MA, Gitschier J, Hayflick SJ.

Nat Genet. 2001 Aug;28(4):345-9.

PMID:
11479594
14.

Magnetic resonance imaging and Hallervorden-Spatz syndrome.

Trimble M.

CNS Spectr. 2003 Jun;8(6):420. No abstract available.

PMID:
12868452
15.

Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein.

Arawaka S, Saito Y, Murayama S, Mori H.

Neurology. 1998 Sep;51(3):887-9.

PMID:
9748051
16.

Coexistence of TDP-43 and tau pathology in neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome).

Haraguchi T, Terada S, Ishizu H, Yokota O, Yoshida H, Takeda N, Kishimoto Y, Katayama N, Takata H, Akagi M, Kuroda S, Ihara Y, Uchitomi Y.

Neuropathology. 2011 Oct;31(5):531-9. doi: 10.1111/j.1440-1789.2010.01186.x. Epub 2011 Jan 30. Review.

PMID:
21276079
17.

Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations.

Hayflick SJ, Hartman M, Coryell J, Gitschier J, Rowley H.

AJNR Am J Neuroradiol. 2006 Jun-Jul;27(6):1230-3.

18.

Pantothenate kinase-associated neurodegeneration (Hallervorden-Spatz syndrome).

Gordon N.

Eur J Paediatr Neurol. 2002;6(5):243-7. Review.

PMID:
12374576
19.

HARP syndrome is allelic with pantothenate kinase-associated neurodegeneration.

Ching KH, Westaway SK, Gitschier J, Higgins JJ, Hayflick SJ.

Neurology. 2002 Jun 11;58(11):1673-4.

PMID:
12058097
20.

Childhood disorders of neurodegeneration with brain iron accumulation (NBIA).

Kurian MA, McNeill A, Lin JP, Maher ER.

Dev Med Child Neurol. 2011 May;53(5):394-404. doi: 10.1111/j.1469-8749.2011.03955.x. Review.

Supplemental Content

Support Center